v3.26.1
Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Noncontrolling Interest [Member]
Total
Balance at Dec. 31, 2024 $ 136 $ 133,252,585 $ (129,544,299) $ (328,483) $ 3,379,939
Balance, shares at Dec. 31, 2024 1,355,773        
Issuance of common stock upon exercise of warrants $ 15 390,840 390,855
Issuance of common stock upon exercise of warrants, shares   147,513        
Issuance of common stock upon warrant inducement, net of issuance cost $ 63 2,199,949 2,200,012
Issuance of common stock upon warrant inducement, net of issuance cost, shares   630,376        
Transaction costs associated with warrant inducement (297,021) (297,021)
Stock-based compensation 106,889 106,889
Net loss (3,678,924) (166) (3,679,090)
Consultant Compensation $ 2 63,012 63,014
Consultant compensation, shares   20,000        
Public offering $ 25 1,099,982 1,100,007
Public offering, shares   239,594        
Transaction costs associated with public offering (204,193) (204,193)
Balance at Jun. 30, 2025 $ 241 136,612,043 (133,223,223) (328,649) 3,060,412
Balance, shares at Jun. 30, 2025 2,393,256        
Balance at Mar. 31, 2025 $ 165 134,538,708 (131,489,872) (328,483) 2,720,518
Balance, shares at Mar. 31, 2025 1,644,728        
Issuance of common stock upon exercise of warrants $ 11 42,850 42,861
Issuance of common stock upon exercise of warrants, shares   98,152        
Issuance of common stock upon warrant inducement, net of issuance cost $ 63 2,199,949 2,200,012
Issuance of common stock upon warrant inducement, net of issuance cost, shares   630,376        
Transaction costs associated with warrant inducement (297,021) (297,021)
Consultant settlement $ 2 36,919 36,921
Consultant settlementt, shares   20,000        
Stock-based compensation 90,638 90,638
Net loss (1,733,351) (166) (1,733,517)
Balance at Jun. 30, 2025 $ 241 136,612,043 (133,223,223) (328,649) 3,060,412
Balance, shares at Jun. 30, 2025 2,393,256        
Balance at Dec. 31, 2025 $ 459 142,933,260 (139,719,999) (328,970) 2,884,750
Balance, shares at Dec. 31, 2025 3,305 4,574,977        
Stock-based compensation   10,613     10,613
Net loss     (6,127,124) (166) (6,127,290)
Issuance of Series B Preferred Stock 2,000,000 2,000,000
Issuance of Series B Prefererd Stock, shares 2,000          
Transaction costs associated with Series B Preferred Stock (171,385) (171,385)
Conversions of preferred stock into common stock $ 1,104 (1,104)
Conversions of preferred stock into common stock, shares (4,072) 11,043,927        
Conversion of 2023 Notes $ 51 246,118 246,169
Conversion of 2023 Notes, shares   508,614        
Settlement of restricted stock units $ 10 (10)
Settlement of restricted stock units, shares   100,000        
Consultant Compensation   46,310     46,310
Balance at Jun. 30, 2026 $ 1,624 145,063,802 (145,847,123) (329,136) (1,110,833)
Balance, shares at Jun. 30, 2026 1,233 16,227,518        
Balance at Mar. 31, 2026 $ 929 142,935,443 (143,276,414) (328,970) (669,012)
Balance, shares at Mar. 31, 2026 1,405 9,277,819        
Stock-based compensation 1,870 1,870
Net loss (2,570,709) (166) (2,570,875)
Issuance of Series B Preferred Stock 2,000,000 2,000,000
Issuance of Series B Prefererd Stock, shares 2,000          
Transaction costs associated with Series B Preferred Stock (165,295) (165,295)
Conversions of preferred stock into common stock $ 634 (634)
Conversions of preferred stock into common stock, shares (2,172) 6,341,085        
Conversion of 2023 Notes $ 51 246,118 246,169
Conversion of 2023 Notes, shares   508,614        
Settlement of restricted stock units $ 10 (10)
Settlement of restricted stock units, shares   100,000        
Consultant Compensation 46,310 46,310
Consultant compensation, shares          
Balance at Jun. 30, 2026 $ 1,624 $ 145,063,802 $ (145,847,123) $ (329,136) $ (1,110,833)
Balance, shares at Jun. 30, 2026 1,233 16,227,518